Clinical Trial: Efficacy of Daratumumab to Overcome Platelet Transfusion Refractoriness in Patients with Aplastic Anemia
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Aplastic Anemia
Study Type: INTERVENTIONAL
Official Title: Efficacy of Daratumumab to Overcome Platelet Transfusion Refractoriness in Patients with Aplastic Anemia
Brief Summary:
This is a phase 1, prospective, single-arm, open-label study.The aim of this study is to evaluate the transfusion responses of platelet increment by using Daratumumab among aplastic anemia patients with platelet transfusion refractoriness.
Read more